UK NICE

How NICE guidance is accelerating access to innovative migraine treatments

Low obligation Product class Pharmaceuticals Market Access & Reimbursement UK Reimbursement

In this episode, we discuss two innovative migraine treatments recommended by NICE. We explore the rapid uptake across the NHS with our three guests. Podcasts 26 February 2026

Read the official source ↗

Published by UK NICE. HealthSignal links to the original document; the summary above is extracted from the source text.